newsfilter
← Latest News
Business Wire·

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

EQ

Dual and synergistic signaling of IL-15 and IL-21 robustly augments NK and CD8 T cell responses Highlights importance of dual inhibition or activation for therapeutic approaches Equillium Inc. (NASDAQ:EQ), a